Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
- PMID: 19154461
- DOI: 10.1111/j.1464-410X.2008.08255.x
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
Abstract
Objective: To study the concordance between the Gleason scores of needle biopsies and radical prostatectomy (RP) specimens in a population-based registry, to clarify whether the concordance depends on the annual number of RP specimens assessed in the pathology unit, and to identify preoperative clinical factors that predict upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen.
Patients and methods: Through the Cancer Registry of Norway, we identified 1116 patients with available Gleason scores from biopsy and RP specimens. Concordance was evaluated using the kappa coefficient, and predictors of concordance were assessed in univariate and multivariate logistic regression analyses.
Results: The Gleason scores were identical in biopsy and RP specimens in 591 of the 1116 (53%) patients. The biopsy-based Gleason score more often under-graded (38%) than over-graded (9%) the RP-based Gleason score. Pathology units that examined >40 RP specimens annually had a higher concordance between the Gleason score in the biopsy and RP specimen than did lower-volume units. The rate of upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen increased with increasing preoperative prostate-specific antigen serum levels, and with increasing intervals between biopsy and RP.
Conclusions: The concordance in Gleason score between biopsy and RP was highest among the pathology departments that regularly evaluated RP specimens. Careful consideration of clinical factors and biopsy grading might improve the identification of patients considered as suitable for active surveillance.
Similar articles
-
Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.Urol Oncol. 2007 Sep-Oct;25(5):376-82. doi: 10.1016/j.urolonc.2006.08.028. Urol Oncol. 2007. PMID: 17826653
-
Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.Urol Int. 2007;79(4):302-6. doi: 10.1159/000109713. Urol Int. 2007. PMID: 18025846
-
Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.BJU Int. 2009 May;103(9):1190-4. doi: 10.1111/j.1464-410X.2008.08197.x. Epub 2008 Dec 8. BJU Int. 2009. PMID: 19076142
-
The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11. J Urol. 2008. PMID: 18550106
-
Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.BJU Int. 2005 Jun;95(8):1146-52. doi: 10.1111/j.1464-410X.2005.05540.x. BJU Int. 2005. PMID: 15877724 Review.
Cited by
-
Initial Outcomes of Freehand Transperineal Biopsies Regarding Diagnostic Value and Safety: An Early Experience at King Fahad Specialist Hospital, Buraydah, Saudi Arabia.Cureus. 2023 May 21;15(5):e39318. doi: 10.7759/cureus.39318. eCollection 2023 May. Cureus. 2023. PMID: 37351252 Free PMC article.
-
Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.Int J Mol Sci. 2023 Apr 10;24(8):7022. doi: 10.3390/ijms24087022. Int J Mol Sci. 2023. PMID: 37108185 Free PMC article.
-
The prevalence and risk factors of upgrading of Gleason grade group between transrectal ultrasound prostate biopsy and prostatectomy specimens.Urol Ann. 2023 Jan-Mar;15(1):18-21. doi: 10.4103/ua.ua_116_21. Epub 2022 Sep 16. Urol Ann. 2023. PMID: 37006215 Free PMC article.
-
ImaGene: a web-based software platform for tumor radiogenomic evaluation and reporting.Bioinform Adv. 2022 Nov 10;2(1):vbac079. doi: 10.1093/bioadv/vbac079. eCollection 2022. Bioinform Adv. 2022. PMID: 36699376 Free PMC article.
-
Multi-Stage Classification-Based Deep Learning for Gleason System Grading Using Histopathological Images.Cancers (Basel). 2022 Nov 29;14(23):5897. doi: 10.3390/cancers14235897. Cancers (Basel). 2022. PMID: 36497378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
